Source: Town Hall
by Sally C Pipes
“A federal judge in New Jersey recently dismissed a lawsuit seeking to strike down the Inflation Reduction Act’s program of price controls for prescription drugs dispensed through Medicare. It was the fifth suit of its kind to fail this year. Democrats have cheered the IRA’s price controls for supposedly making drugs more accessible to seniors. But they have an insidious downside. By slowing the pace of new drug innovation, price controls will seriously harm Americans with cancer now and in the future. To make up for revenue lost due to price controls, drug manufacturers are reducing spending elsewhere, including on research and development.” [editor’s note: Now if Pharma would just stop promoting limited-use, high-side effect “cures” as general-public panaceas … – SAT] (12/04/24)